Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul E. Wiedeman is active.

Publication


Featured researches published by Paul E. Wiedeman.


Tetrahedron Letters | 2001

Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721

David J. Madar; Hana Kopecka; Daisy Pireh; Jonathan Pease; Marina Pliushchev; Richard J. Sciotti; Paul E. Wiedeman; Stevan W. Djuric

Abstract A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-721 are described.


Bioorganic & Medicinal Chemistry Letters | 2008

Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase

Yaya Liu; Pamela L. Donner; John K. Pratt; Wen W. Jiang; Teresa Ng; Vijaya Gracias; Steve Baumeister; Paul E. Wiedeman; Linda Traphagen; Usha Warrior; Clarence J. Maring; Warren M. Kati; Stevan W. Djuric; Akhteruzzaman Molla

Halosalicylamide derivatives were identified from high-throughput screening as potent inhibitors of HCV NS5B polymerase. The subsequent structure and activity relationship revealed the absolute requirement of the salicylamide moiety for optimum activity. Methylation of either the hydroxyl group or the amide group of the salicylamide moiety abolished the activity while the substitutions on both phenyl rings are acceptable. The halosalicylamide derivatives were shown to be non-competitive with respect to elongation nucleotide and demonstrated broad genotype activity against genotype 1-3 HCV NS5B polymerases. Inhibitor competition studies indicated an additive binding mode to the initiation pocket that is occupied by the thiadiazine class of compounds and an additive binding mode to the elongation pocket that is occupied by diketoacids, but a mutually exclusive binding mode with respect to the allosteric thumb pocket that is occupied by the benzimidazole class of inhibitors. Therefore, halosalicylamides represent a novel class of allosteric inhibitors of HCV NS5B polymerase.


Tetrahedron Letters | 1985

A relay approach to (+)-pleuromutilin. III. direct degradation of the natural product to the key diketone intermediate and its chemospecific functionalization

Leo A. Paquette; Paul E. Wiedeman; Philip C. Bulman-Page

Abstract Pleuromutilin or tiamulin can be degraded to the important bicyclic relay compound (−)- 1 in only four steps. Various methods for achieving chemoselective functionalization of 1 are set in focus.


Tetrahedron Letters | 1985

A relay to (+)-pleuromutilin. I. De novo synthesis of a levorotatory tricyclic lactone subunit

Leo A. Paquette; Paul E. Wiedeman

Abstract Construction of the optically active lactone (−)−13, required for a proposed total synthesis of (+)-pleuromutilin, has been successfully achieved.


Archive | 2004

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Zhonghua Pei; Xiaofeng Li; Kenton L. Longenecker; Hing Leung Sham; Paul E. Wiedeman


Journal of Medicinal Chemistry | 2000

3,5-Bis(trifluoromethyl)pyrazoles: A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djuric; Nwe Y. BaMaung; Basha A; Liu H; Luly; David J. Madar; Sciotti Rj; Tu Np; Wagenaar Fl; Paul E. Wiedeman; Zhou X; Stephen J. Ballaron; Joy Bauch; Chen Yw; Chiou Xg; Thomas A. Fey; Donna M. Gauvin; Gubbins E; Gin C. Hsieh; Kennan C. Marsh; Karl W. Mollison; Pong M; Shaughnessy Tk; Sheets Mp; Morey L. Smith; James M. Trevillyan; Usha Warrior; Wegner Cd; George W. Carter


Archive | 2001

Oxazolidinone antibacterial agents

David J. Madar; Daisy Pireh; Hana Kopecka; Steven W. Djuric; Paul E. Wiedeman


Archive | 1999

Azole inhibitors of cytokine production

Nwe Y. BaMaung; Anwer Basha; Stevan W. Djuric; Earl J. Gubbins; Jay R. Luly; Noah P. Tu; David J. Madar; Usha Warrior; Paul E. Wiedeman; Xun Zhou; Richard J. Sciotti; Frank L. Wagenaar


Journal of Medicinal Chemistry | 2006

Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.

Zhonghua Pei; Xiaofeng Li; Kenton L. Longenecker; Thomas W. von Geldern; Paul E. Wiedeman; Thomas H. Lubben; Bradley A. Zinker; Kent D. Stewart; Stephen J. Ballaron; Michael A. Stashko; Amanda K. Mika; David W. A. Beno; Michelle A. Long; Heidi Wells; Anita J. Kempf-Grote; David J. Madar; Todd S. McDermott; Lakshmi Bhagavatula; Michael G. Fickes; Daisy Pireh; Larry R. Solomon; Marc R. Lake; Rohinton Edalji; Elizabeth H. Fry; Hing L. Sham; James M. Trevillyan


Archive | 2004

Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)

Zhonghua Pei; Xiaofeng Li; Kenton L. Longenecker; Hing Leung Sham; Paul E. Wiedeman

Collaboration


Dive into the Paul E. Wiedeman's collaboration.

Top Co-Authors

Avatar

David J. Madar

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Jay R. Luly

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Megumi Kawai

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Stevan W. Djuric

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard J. Sciotti

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Stevan W. Djuric

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge